biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by Yoshitoshion Apr 04, 2013 1:40pm

154 Views

Post# 21211523

RE: RE: 'peripheral' considerations

lol jdcrocs... you're the garbage can and the waste of bandwidth... the post wasn't intended for you as you told the board yesterday ( in a huff ) that you weren't posting here anymore... it was for the rest of the board to read and i'm sure most here appreciate the free information that Sinbob provides about the state that this planet is in.

Not sure what you are talking about... Sinbob has posted a wealth of relative information about BTI for the past 1.5 years now... you know all those " bubbles " everyone talks about... i think you are in one yourself " the jdcrocs ego bubble "

Bullboard Posts

Global Tungsten Market and Supply Security